GlassScriptPrepare for your visit
Sonika Malik
Endocrinology, Diabetes & Metabolism · Florence, SC · NPI 1346602810
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,931.21
in general payments reported to CMS, 2019-2025 · $1,604 in 2025
The $1,604 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Who reported paying
General payments only, top 6 by amount.
- Lilly USA, LLC $733.17
- Novo Nordisk INC $498.81
- Abbott Laboratories $406.48
- Sanofi-Aventis U.S. LLC $398.49
- Insulet Corporation $232.66
- Boehringer Ingelheim Pharmaceuticals, INC. $220.66
Drugs and devices associated with these payments
Ilet Bionic Pancreas Jardiance Tzield Freestyle Libre 3 Mounjaro Ozempic Omnipod Rybelsus Zepbound Korlym Sogroya Evenity
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Sonika Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/2788128/sonika-malik